Contact
Cover image of company Ksilink
Company logo of Ksilink

Ksilink

Ksilink is a private-public translational center and association for phenotypic drug discovery and preclinical development of novel therapies. Ksilink was founded in 2014 in Strasbourg, France. Together with its industrial and academic partners, Ksilink enables highly innovative translational programs with a focus on AI-assisted phenotypic profiling technologies for novel patient-based therapy development. Ksilink provides unique expertise in the fields of high-throughput, high content screening (HTS / HCS), image analysis using machine and deep-learning techniques, and preclinical drug development in an integrated and fully industrialized approach.
20-49
2014
Pharma & Medical engineering

Stories

6

Events

0

Jobs

0

ShortNews

1

We offer

  • An integrated drug discovery value chain up to preclinical canditas & AI assisted phenotypic profiling services

We're looking for

  • Patient-based disease models to be translated up to preclinical canidates
The publisher indicated in each case (see company info by clicking on image/title or company info in the right-hand column) is solely responsible for the stories above, the event or job offer shown and for the image and audio material displayed. As a rule, the publisher is also the author of the texts and the attached image, audio and information material. The use of information published here is generally free of charge for personal information and editorial processing. Please clarify any copyright issues with the stated publisher before further use. In case of publication, please send a specimen copy to service@pressebox.de.
Important note:

Systematic data storage as well as the use of even parts of this database are only permitted with the written consent of unn | UNITED NEWS NETWORK GmbH.

unn | UNITED NEWS NETWORK GmbH 2002–2024, All rights reserved

The publisher indicated in each case (see company info by clicking on image/title or company info in the right-hand column) is solely responsible for the stories above, the event or job offer shown and for the image and audio material displayed. As a rule, the publisher is also the author of the texts and the attached image, audio and information material. The use of information published here is generally free of charge for personal information and editorial processing. Please clarify any copyright issues with the stated publisher before further use. In case of publication, please send a specimen copy to service@pressebox.de.